IMPORTANCE Limited data exist on the prevalence and prognostic importance of right ventricular (RV) dysfunction for heart failure (HF) in the general population.
R ight ventricular (RV) dysfunction is prognostic of adverse outcomes independent of left ventricular (LV) dysfunction across a broad spectrum of cardiovascular diseases. [1] [2] [3] [4] [5] [6] [7] [8] [9] Limited data exist regarding the prevalence and predictive value of RV dysfunction in the general population, particularly among elderly individuals, who are at a heightened risk for HF. Furthermore, the RV is highly afterload sensitive.
Recognized age-associated increases in LV stiffness, LV filling pressure, and pulmonary pressure suggest that elderly individuals may be at particular risk for RV dysfunction owing to impaired RV-pulmonary artery (RV-PA) coupling. 10 The RV has a complex 3-dimensional (3-D) shape, which makes accurate quantification of RV size and function challenging by 2-dimensional (2-D) echocardiography. Alternative approaches include cardiac magnetic resonance imaging (CMR), 1 radionuclide ventriculography, 2 or right heart catheterization, 3, 4 but are limited by cost, duration, radiation exposure, and invasiveness. Therefore, only limited community-based data are available regarding correlates and prognostic value of RV structure and function and RV-PA coupling. Three-dimensional echocardiography allows for the direct quantification of RV volumes and RV ejection fraction (RVEF) without relying on geometric assumptions regarding RV shape. Right ventricular ejection fraction demonstrates good accuracy relative to CMR, as do RV volumes, particularly when not significantly enlarged.
11-14 Professional guidelines now recommend the use of 3-D echocardiography in the assessment of RV disorders. 15 We used 3-D echocardiography to determine the alterations in RV function across American College of Cardiology Foundation/American Heart Association (ACCF/AHA) HF stages and its prognostic relevance for incident HF or death among elderly participants in the community-based Atherosclerosis Risk in Communities (ARIC) study. 16 
Methods

Study Setting
The ARIC is a population-based cohort study from 4 US communities (Forsyth County, North Carolina; Jackson, Mississippi; Minneapolis, Minnesota; and Washington County, Maryland). The design and methods have been previously described. 16 In brief, 15 792 middle-aged participants were enrolled between 1987 and 1989, and 6538 participants returned between 2011 and 2013 for a fifth study visit, at which time 2-D and 3-D echocardiography were performed. 17 This study included the 1225 participants attending the fifth study visit who underwent 3-D and 2-D echocardiography with previously quantified 3-D LV and left arterial (LA) deformation. 18, 19 Of these participants, 1004 (82%) had optimal quality 3-D RV data (eFigure 1 in the Supplement). The study protocol was approved by institutional review boards at each field center, and additional approval was obtained by the ARIC steering committee. All participants provided written informed consent.
2-D Echocardiography
Design and methods of echocardiography in ARIC at visit 5 have been previously described in detail, including data on interobserver variability. 17, 19 Pulmonary artery systolic pressure (PASP) was calculated from the peak tricuspid regurgitation velocity by continuous wave Doppler as PASP=4× (peak velocity TR 2 )+5. [20] [21] [22] Mean pulmonary artery pressure (PAP) was calculated based on the tricuspid regurgitation velocity (TRV)-time integral as previously validated. 22, 23 Pulmonary vascular resistance (PVR) was estimated as 10 × TRV/VTI RVOT . 24 Right ventricular stroke volume (SV) was calculated as RV end-diastolic volume (EDV) -RV endsystolic volume (ESV). Pulmonary capillary wedge pressure (PCWP) was estimated as PCWP = 11.96 + 0.596 × (E/e′septal).
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Right ventricular function was assessed based on the RV fractional area change, calculated as (RV end-diastolic area -RV end-systolic area)/RV end-diastolic area and tissue Dopplerbased tricuspid annular peak systolic velocity. 25 
3-D Echocardiography
A full-volume echocardiography-gated 3-D data set was acquired from the apical position with a matrix-array 3-D transducer during breath hold with the highest frame rate achievable (20-26 Hz in our study), as previously described. 19 This frame rate is in accordance with guideline recommendations, 26 and higher than prior publications using this analysis software. 11 Offline analysis was performed to measure RV volumes, RVEF, and RV freewall longitudinal strain (RVLS) using a semiautomatic algorithm (4-D RV-Function 2.0; TomTec Imaging Systems; Figure 1 ). The reproducibility and accuracy of this software when compared with CMR has been previously demonstrated.
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A single experienced cardiologist blinded to participant characteristics performed image quality assessment and subsequent analysis. Poor-quality data set was defined as significant acquisition artifacts (eg, stitch artifacts) or suboptimal endocardial definition. Quantitative measures were performed based on the recommendations of the American Society of Echocardiography. 27 The RV-PA coupling was assessed as
Key Points
Question Is subclinical right ventricular dysfunction associated with heart failure risk among elderly persons?
Findings In this secondary analysis of a community-based cohort study, subclinical right ventricular dysfunction assessed by 3-dimensional echocardiography was present in nearly one-fifth of elderly persons, was associated with common heart failure risk factors, and increased in prevalence with more advanced American College of Cardiology/American Heart Association heart failure stage. When identified, asymptomatic right ventricular dysfunction identified individuals at heightened risk for the development of heart failure hospitalization or death independent of left ventricular ejection fraction and N-terminal pro b-type natriuretic.
Meaning These findings suggest an important and underrecognized role of right ventricular dysfunction in the progression to heart failure and the potential utility of 3-dimensional echocardiography to more accurately assess right ventricular performance. 
Definitions of ACCF/AHA HF Stages
The ACCF/AHA HF stages were defined as follows: stage A (at elevated risk for HF but without structural heart disease or symptoms of HF), stage B (structural heart disease but without signs or symptoms of HF), and stage C (structural heart disease with earlier or current symptoms of HF 
Statistical Methods
Clinical characteristics and 2-D/3-D echocardiographic measures were described by quartile of 3-D RVEF. Reference limits for 3-D measures were determined among stage 0 participants (low-risk; free of HF risk factors or structural heart disease) using quantile regression to define median, 10th, and 90th percentile limits with associated 95% confidence limits. Differences in 3-D RV measures and the prevalence of abnormal values between categories were assessed using multivariable linear and logistic regression models adjusting for age, sex, and race/ethnicity. The association between measures of RV function and a composite of HF hospitalization or all-cause death among participants free of prevalent HF at visit 5 was assessed using multivariable Cox regression models adjusted for age, sex, race/ethnicity, LVEF, and NT-proBNP. To assess the effect of potential selection bias related to unavailable 3-D RV measures owing to either unanalyzed or unanalyzable 3-D data or visit 5 nonattendance, we performed a sensitivity analysis using inverse probability of attrition weighting (IPAW) as detailed in eTables 2-5 in the Supplement. 34,35 A 2-sided P value of less than .05 was considered statistically significant. All analyses were performed with Stata, version 15 (StataCorp).
Results
The mean (SD) age of the 1004 study participants was 76 (5) years, 619 were women (62%), and 121 were black (12%). Twodimensional echocardiography-based measures of RV size and function did not differ appreciably between participants at visit 5 included vs not included in this 3-D analysis (eTable 2 in the Supplement). Mean (SD) values in 3-D RVEF and RVLS were 53.2% (8.2%) and −27.1% (8.2%), respectively (eFigure 2 in the Supplement). Worse 3-D RVEF was associated with male sex, higher body mass index, higher prevalence of cardiovascular diseases including coronary disease, stroke, and atrial fibrillation, and higher high-sensitivity troponin-T concentrations (Table) . Right ventricular ejection fraction was significantly, but modestly, associated with 2-D echo-based measures of RV function including RV fractional area change (r = 0.23; P < .001) and tricuspid annular s′ (r = 0.14; P < .001 ). Right ventricular ejection fraction was abnormal in 173 (17%) of the total study sample and RVLS was abnormal in 198 (20%) (eFigure 2 in the Supplement).
Physiologic Associations With RVEF
Mean (SD) PAP was 15.2 (3.4) mm Hg (>25 mm Hg in 0.4%) and mean (SD) PVR was 1.75 (0.41) WU (>2 WU in 15.4%). Higher PVR was significantly, although modestly, associated with lower RVEF, even after adjustment for PCWP (−3.18; 95% CI, −4.65 to −1.72; P < .001; eFigure 3A in the Supplement). No significant linear or nonlinear (data not shown) association was noted between RVEF and MPAP (eFigure 3B in the Supplement). The RVEF was directly associated with RV SV (R = 0.31, P < .001). Similar associations were noted for RVLS (eFigure 4 in the Supplement).
Lower RVEF was associated with greater LV mass, wall thickness, LA size, and lower TDI e′, even after adjusting for age, sex, race/ethnicity, and PVR (Table) . Lower RVEF was also associated with larger LVESV and lower LVEF, longitudinal strain, twist, and torsion (Table) . Right ventricular LS demonstrated similar associations with LV structure and function ( Figure 2B ; eFigure 4 in the Supplement). Concordant findings were observed in IPAW analysis (eTable 3 in the Supplement).
RV Structure and Function Across HF Stages
Eighty-three participants (8%) were classified as stage 0, 676 (67%) were stage A, 114 (11%) were stage B, and 131 (13%) were stage C. Across HF stages, significant trends were observed for higher RV volumes, lower RVEF, and worse RVLS (Figure 2 ; eFigure 5 in the Supplement), with progressive decrements noted in stage A and stage B HF. Right ventricular-PA coupling, assessed as the RVEF/PASP ratio, also declined across HF stages consistent with worse RV systolic function accounting for RV afterload. The highest prevalence of RV dysfunction was in stage C, among whom RVEF was abnormally low in 28 (25%) and RVLS was impaired in 49 (37%) (Figure 3) . Similar findings were observed in sensitivity analyses incorporating inverse probability weights (eTable 4 in the Supplement).
Association of RV Function With All-Cause Mortality or Incident HF
Of the 847 participants free of prevalent HF at visit 5, 59 (7.0%) experienced the composite outcome of incident HF hospitalization or all-cause mortality during a median follow-up of 4.1 years (25th and 75th percentile limits, 3.8-4.3 years). Lower RVEF at visit 5 was significantly and linearly associated with a higher event rate during follow-up ( Figure 4A ). After adjustment for age, sex, race/ethnicity, LVEF, and NT-proBNP, each 5% decrease in RVEF was associated with a 20% increase in the hazard for death or HF hospitalization (adjusted HR per 5% decrease in RVEF, 1.20; 95% CI, 1.02-1.42; P = .03; Figure 4A ). This association remained significant after further adjusting for left atrial volume index (HR, 1.20; 95% CI, 1.02-1.42; P = .03) or E/e′ (HR, 1.18; 95% CI, 1.00-1.40; P = .05). Lower RVEF/PASP ratio, reflecting worse RV-PA coupling, was also associated with a higher risk of death or incident HF (demographic, LVEF, and NT-proBNP-adjusted HR per 0.5 unit decrease, 1.58; 95% CI, 1.10-2.28; P = .01; Figure 4B ), which persisted after further adjustment for left atrial volume index (HR, 1.59; 95% CI, 1.10-2.30; P = .01) or E/e′ (HR, 1.58; 95% CI, 1.09-2.29; P = .02). Similar findings were observed in IPAW analyses (eTable 5 in the Supplement). Right ventricular LS was not significantly associated with risk of incident HF or death (HR per 1% decrease, 1.03; 95% CI, 0.99-1.07; P = .14 adjusting for age, sex, and race/ethnicity). Furthermore, no significant association with death or incident HF was noted for RV fractional area change (HR per 1% decrease, 1.02; 95% CI, 0.99-1.06; P = .22) or tricuspid annular s′ (HR per 1 cm/s decrease, 1.07; 95% CI, 0.96-1.19; P = .23) after adjustment for age, sex, race/ethnicity, and LVEF.
Discussion
In what is, to our knowledge, one of largest studies to quantify RV function (RVEF and RVLS) and RV-PA coupling (RVEF/PASP ratio) in a community-based sample, our study Current smoking 15 (6) 17 (7) 16 (7) 11 (5) 17 (7) .62
Prevalent CVD CAD 126 (13) 48 (19) 25 (10) 24 (10) 29 (12) .003
Prior MI 66 (7) 29 (12) 13 (6) 16 (7) 8 (4) .001
Stroke 33 (3) 15 (6) 13 (5) 3 (1) provides important, novel insights into the potential predictors of RV dysfunction and its association with HF risk. We report 3 novel findings: first, RV systolic function and RV-PA coupling decline progressively across ACCF/AHA HF stages, and RV function is impaired in nearly one-fourth of asymptomatic persons with stage B HF. Second, while RVEF is inversely associated with RV afterload, it is also associated directly with LV function independent of pulmonary vascular measures, suggesting parallel alterations in biventricular function. Third, among persons free of HF, both worse RVEF and worse RV-PA coupling are linearly associated with heighted risk of incident HF or death independent of LVEF, NT-proBNP, and measures of LV filling pressure. These associations were not observed for RV function assessed by RV fractional area change and tricuspid annular s′. These data suggest an important and underrecognized role of RV dysfunction in the progression to HF and suggest the potential utility of 3-D echocardiography to more accurately assess RV performance.
Previous studies of RV function have typically focused on patients with established cardiovascular disease, including HF, 2-6 myocardial infarction, 1 or pulmonary arterial Tests for trend across HF stages were performed using multivariable linear regression models adjusting for age, sex, and race/ethnicity. Solid line indicates incidence rate per 100 person-years at any given value of RVEF or RV-PA coupling. Dashed lines indicate the 95% confidence intervals for these incidence rates. Histograms show the population distribution of RVEF (A) and RV-PA coupling (B). The RV-PA coupling is assessed as the RVEF/PA systolic pressure ratio. After adjustment for age, sex, race/ethnicity, left ventricular ejection fraction, and N-terminal pro b-type natriuretic, the hazard ratio (HR) for all-cause mortality or incident heart failure per 5% decrease in RVEF was 1.20 (95% CI, 1.02-1.42; P = .03). The adjusted HR per 0.5 unit decrease in RVEF/PASP ratio was 1.58 (95% CI, 1.10-2.28; P = .01). Abnormal limits were based on the 90th or 10th percentile limits derived from the stage 0 participants. Test for trend of the proportion with abnormal measures across HF stages was performed using multivariable logistic regression models adjusting for age, sex, and race/ethnicity. data on RV performance in elderly individuals and its association with HF risk. Among our large community-based elderly sample, we identified 83 participants free of cardiovascular disease or risk factors. Reference limits for RVEF (>45.5%) and RVLS (<21.9%) derived from this subgroup using quantile regression were consisted with a previous study in a healthy sample (n = 37, age >70 years) 37 and with professional guidelines (RVEF <45%; GLS <20%).
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The RV is known to be particularly afterload sensitive, such that RVEF is inversely associated with MPAP or PVR in conditions such as pulmonary arterial hypertension or advanced HF with reduced LVEF. 4, 39 In our study, lower RVEF was associated with higher RV afterload as assessed by PVR and also with lower RV stroke volume, possibly explaining its lack of association with flow-dependent measures of afterload such as PA pressure. Lower RVEF and RVLS were also associated with worse LV systolic function (higher LV end-systolic volume, lower LVEF, and worse GLS) and LV diastolic function (larger LA size and lower e′). Importantly, these associations remained significant after accounting for pulmonary vascular measures, suggesting that greater RV afterload secondary to elevated LV filling pressure does not fully account for these associations. This is consistent with prior studies that identify RV dysfunction in early stage hypertension 40 Together, these findings suggest parallel effects on biventricular function independent of the pulmonary vasculature. The ACCF/AHA construct of HF stages was introduced to emphasize the progressive nature of HF, whereby risk factors promote detrimental alterations in cardiac structure and function, which in turn underlie clinical symptomatic HF. While the LV has been the primary focus for these cardiac alterations, we demonstrate that RV size increases and RV function, as reflected in RVEF, RVLS, and RV-PA coupling, decreases across HF stages. The prevalence of impaired RVEF increased by nearly 3-fold from stage 0 to stage B HF (asymptomatic stages) and was abnormal in one-fourth of stage B participants. We also demonstrate that reductions in RVEF in these asymptomatic stages (0 through B) are prognostically relevant, with each 5% decrease in RVEF associated with a 20% increase risk of death or HF hospitalization independent of demographics, LVEF, and NT-proBNP. Impaired RV-PA coupling also decreased with more advanced HF stage, was impaired in nearly one-half of stage C participants, and, among HF-free participants, was independently associated with incident HF or death. As PA pressure also increases across HF stages and is associated with incident HF, these findings support the importance of primary RV dysfunction, accounting for afterload, for HF.
By demonstrating the prognostic importance of alterations in RV function in a population-based sample, our findings extend on CMR-based data from the Multi-Ethnic Study 47 We now extend the prognostic relevance of RVEF to a community-based sample, largely free of prevalent cardiovascular disease, and focus on HF as a particularly relevant end point.
Limitations
Several limitations of this analysis should be noted. Of ARIC participants alive at the fifth visit, 6538 (64%) attended, which may have introduced ascertainment bias. Quantitative 3-D echocardiographic data on the RV were available in a relatively small proportion of participants attending visit 5, which may result in further selection bias. However, sensitivity analysis by IPAW provided consistent findings (eTable 2-5 in the Supplement), suggesting that the influence of bias on our findings is small, and among visit 5 attendees, RV size and function assessed by 2-D echocardiography did not differ clinically between those included vs not included in this 3-D analysis (eTable 2 in the Supplement). Second, we were not able to provide reference limits based on sex owing to the small number of men in stage 0. However, our use of indexed values for volumes should have minimized expected sex-based differences, and our reference values generally align with those of prior studies and guidelines. 15 Third, M-mode of the tricuspid annular was not acquired in ARIC at visit 5, and therefore we were not able to evaluate the association of the tricuspid annular plane systolic excursion (TAPSE) or the TAPSE/PASP ratio with HF stages or incident HF or death. The TAPSE/ PASP ratio is one of the most commonly used echocardiographic measures of RV-PA coupling, and we are unable to evaluate its performance relative to 3-D echocardiographybased RVEF/PASP ratio. However, TAPSE was initially validated against RVEF, 48 and the RVEF/PASP ratio has previously been used as a measure of RV-PA coupling. 28,29 Follow-up time after echocardiography at visit 5 was relatively short (median, 4.1 years) and the number of events relatively small (n = 59), which limited our power to assess the incremental prognostic value of 3-D echocardiographic measures of RV function over conventional echocardiographic measures. We were also unable to adjust for comorbidities, such as obesity, coronary disease, and atrial fibrillation, that were associated with RV functional measures and are established risk factors for HF. We therefore could not determine the prognostic relevance of RV dysfunction independent of these comorbidities, although RV dysfunction itself may be one means by which these comorbidities increase HF risk. Three-dimensional echocardiography-based RVLS did not demonstrate clear advantages vs 3-D RVEF in this study. However, the relatively low frame rates for 3-D images (20-26 Hz) compared with those for 2-D echocardiography (50-80 Hz) may have resulted in reduced sensitivity and/or precision of 3-D-based RVLS. While our data are not sufficient to demonstrate superiority of 3-D compared with 2-D echocardiography-based RV assessments to predict HF, they support further studies evaluating the utility of 3-D echocardiography to detect RV dysfunction and risk for HF.
Conclusions
In a large, community-based cohort of older persons, RV function and RV-PA coupling declined progressively across ACCF/AHA HF stages, with a nearly 3-fold increase in prevalence RV dysfunction from stage 0 to stage B HF, and is impaired in more than one-fourth of asymptomatic persons with stage B HF. Among persons free of HF, lower RVEF and lower RVEF/PASP ratio are linearly associated with a heighted risk of incident HF or death independent of LVEF and NT-proBNP. These data suggest an important and underrecognized role of RV dysfunction in the progression to HF and suggest the potential utility of 3-D echocardiography to more accurately assess RV performance.
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3D RV measure non-availability was modeled among participants all ARIC participants alive at the initiation of visit 5 using the following covariates from Visit 1: age, gender, race, study center, systolic blood pressure, heart rate, body mass index, smoking and drinking status, diabetes mellitus, hypertension, and chronic kidney disease. The resulting calculated weights were incorporated into multivariable models for prevalence of abnormal and time-to-event analysis. 3D RV measure non-availability was modeled among participants all ARIC participants alive at the initiation of visit 5 using the following covariates from Visit 1: age, gender, race, study center, systolic blood pressure, heart rate, body mass index, smoking and drinking status, diabetes mellitus, hypertension, and chronic kidney disease. The resulting calculated weights were incorporated into multivariable models for prevalence of abnormal and time-to-event analysis. Caption: Linearity of the associations between RV functional measures (3D RVEF, RVLS) with PVR, mean PAP, LVEF, and LVGLS was assessed by fitting adjusted linear and restricted cubic spline models. The number of knots was selected based on the number of knots producing the lowest Baysian information criterion (BIC), with 3 to 6 knots tested. We assumed that the relationship was approximately linear if the linear model resulted in the lowest BIC. Using this approach, for no associations did the restricted cubic spline models improved the BIC beyond the linear model. Therefore, all associations were assumed to be approximately linear. Caption: Linearity of the associations between RV functional measures (3D RVEF, RVLS) with PVR, mean PAP, LVEF, and LVGLS was assessed by fitting adjusted linear and restricted cubic spline models. The number of knots was selected based on the number of knots producing the lowest Baysian information criterion (BIC), with 3 to 6 knots tested. We assumed that the relationship was approximately linear if the linear model resulted in the lowest BIC. Using this approach, for no associations did the restricted cubic spline models improved the BIC beyond the linear model. Therefore, all associations were assumed to be approximately linear. Comparison of the proportion with abnormal measures across HF stages was performed by trend testing using multivariable logistic regression models adjusting for age, sex, and race. 
